Engflag

Clomaderm

Quick links to important sections

Clomaderm

Clomaderm_TR

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clomaderm

Property Description
Active Ingredient Clotrimazole
Forms Cream, Solution, Lotion, Vaginal Tablet
Pharmacological Class Antifungal Agent, Azole Antifungal
Route of Administration Topical, Intravaginal
Origin Synthetic Compound

What Type of Medicine is Clomaderm?

Clomaderm is a medicinal preparation whose active component is Clotrimazole, a synthetic compound specifically classified as an Azole antifungal agent. Its core function is to counter the growth and proliferation of susceptible fungi and yeasts.

The fundamental identity of the medication derives from its pharmacological class: it is an antifungal agent that belongs chemically to the group of imidazole derivatives. This classification establishes the drug's specialized therapeutic role, which is distinctly focused on addressing fungal pathogens. Clomaderm is typically a single active ingredient product (monotherapy), designed to deliver the focused effect of Clotrimazole without reliance on additional pharmacologically active components. The efficacy of this single-agent approach has been clinically recognized for decades as a standard initial therapy for various superficial fungal manifestations.

What is the Composition and Common Form of Clomaderm?

The primary active ingredient in Clomaderm is Clotrimazole, which is formulated for direct application to the affected areas of the body. Clomaderm is specifically positioned as a product optimized for the topical route of administration, most commonly presented as an external, emollient cream or a liquid solution.

This medication is presented in various dosage form(s), including cream, solution, and sometimes lozenges or tablets for intravaginal or specific oral topical use. Clotrimazole is effective at eliminating fungal organisms due to its potent fungicidal action. The distinction between a cream base and a solution base primarily allows for effective delivery across different body surfaces, such as dry skin versus skin folds, ensuring that a high local concentration of the active ingredient is achieved where it is most needed.

How Does Clotrimazole Achieve Its Purpose?

Clotrimazole achieves its purpose by disrupting the fundamental structure required for fungal survival, ultimately eliminating the organism causing the issue. This Azole antifungal works by blocking the fungal organism’s ability to synthesize ergosterol, a fat-like substance that is vital for building and maintaining the fungal cell membrane.

This targeted action, known as Ergosterol synthesis inhibition, destabilizes the fungal cell's protective outer layer, making it structurally flawed and leaky. By directly damaging the membrane integrity, Clomaderm ensures that the fungal organism cannot survive or reproduce, providing the general therapeutic benefit of directly eliminating the fungal cause.

Regulatory References

  1. National Library of Medicine/MedlinePlus

What side effects are possible with Clomaderm?

Possible Side Effects and Safety Information

The documented safety profile of Clotrimazole, the active ingredient in Clomaderm, consists primarily of local reactions that manifest at the site of application. According to official regulatory documents, the frequency of many localized adverse reactions is classified as not known, meaning it cannot be reliably estimated from available data. Adverse effects are categorized by the physiological system affected, most commonly impacting Skin and subcutaneous tissue disorders and General disorders and administration site conditions.

Commonly documented local effects include a burning sensation or stinging, erythema (redness), and general irritation at the treatment site. Other reported skin-related effects may include pruritus (itching), peeling of the skin, and the appearance of a rash. For intravaginal preparations, effects such as abdominal pain, pelvic pain, or nausea have been reported.

Safety information also recognizes the potential for reactions affecting the Immune system disorders, including hypersensitivity reactions such as urticaria (hives) and oedema (swelling). In rare instances, more severe systemic allergic reactions, classified as serious adverse reactions, are documented, which may include anaphylactic reaction, syncope, and dyspnoea.

A specific safety constraint explicitly documented for the intravaginal formulations is the interaction with latex contraceptive products. Concomitant use with the cream or vaginal tablets may result in damage to latex products, such as condoms and diaphragms, which can lead to a reduction in their effectiveness. For high-level safety considerations, the use of Clotrimazole during pregnancy and lactation should be initiated with appropriate medical consultation.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that the risk of acute intoxication following a topical or vaginal overdose of Clomaderm (Clotrimazole) is minimal because systemic absorption of the active ingredient through the skin or mucosa is negligible.

Documented Overdose Scenarios

The primary concern noted in official documentation relates to the accidental oral ingestion of the product. The government-authorized labeling states that swallowing Clomaderm may potentially lead to clinical manifestations of overdose, which include:

  • Dizziness
  • Nausea
  • Vomiting

Required Emergency Actions

In the event of accidental oral ingestion of Clomaderm, the official guidance is to seek professional assistance or contact a doctor or nearest hospital emergency department immediately for advice.

Management of an overdose resulting from oral ingestion is generally symptomatic and supportive. Regulatory information confirms that no specific antidote is known for Clotrimazole. Aggressive procedures, such as gastric lavage, are described as rarely required and are only considered if significant symptoms are apparent or if a life-threatening quantity was ingested.

Additionally, patients using oral immunosuppressants such as tacrolimus or sirolimus concomitantly with Clomaderm must be closely monitored for signs of overdosage of the immunosuppressant, as Clotrimazole may increase their plasma levels.

Therapeutic Uses of Clomaderm

What Clomaderm Treats: Main Uses and Benefits

The primary purpose of Clomaderm (Clotrimazole) is to offer targeted therapeutic support in managing localized infections caused by common fungal and yeast pathogens. This focus is relevant for managing symptom clusters that may become intense or disruptive, contributing to improved comfort during symptomatic periods. Specifically, this medication is used to treat Tinea infections and yeast infections of the skin.

Clomaderm is commonly used across conditions presenting with acute episodes, where symptomatic support is needed for dermatomycoses and candidiasis, which includes manifestations such as Tinea pedis (athlete's foot), Tinea cruris (jock itch), Tinea corporis (ringworm), and vulvovaginal candidiasis. It is applied during phases when the patient experiences heightened discomfort from intense pruritus (itching) and a noticeable burning sensation.

“The medication is relevant for managing symptoms that interfere with daily comfort.”

By addressing the source of the infection, Clomaderm supports general well-being during symptomatic phases, helping to ease the impact of scaly, red, and cracked skin lesions. It is relevant in clinical settings marked by increased discomfort or tension, assisting with maintaining functional stability when symptoms are more noticeable.

Quick Fact: Symptomatic support for Irritative States

Eligibility and Restrictions for Use

Clomaderm (a combination product typically containing clotrimazole and betamethasone dipropionate) is used to treat certain fungal skin infections that are accompanied by inflammation and itching.

Who Can Use It?

Clomaderm is generally prescribed for adults to treat specific steroid-responsive fungal infections such as tinea cruris (jock itch), tinea corporis (ringworm), and tinea pedis (athlete's foot).

Who Cannot Use It? (Contraindications)

Due to the potent corticosteroid component (betamethasone), the cream should be avoided in several situations. You must not use Clomaderm if:

  • You have a known allergy or hypersensitivity to clotrimazole, betamethasone dipropionate, other corticosteroids, or imidazole antifungals.
  • You have untreated skin infections caused by bacteria, tuberculosis, or viruses (e.g., herpes simplex, chickenpox, vaccinia).
  • The condition being treated is diaper dermatitis (diaper rash).
  • The medication is needed for the face, groin area (for extended periods), or armpits.
  • You are a child under 17 years of age; use is not recommended due to a higher risk of systemic side effects from the corticosteroid.

Cautious use, with careful monitoring by a healthcare provider, is also required for patients with diabetes, Cushing's syndrome, liver impairment, glaucoma, or cataracts, as the topical corticosteroid may worsen these conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Clomaderm (Clotrimazole) has a limited number of officially documented interactions due to its low systemic absorption following topical and vaginal application. Regulatory documentation focuses on two distinct types of interactions: a pharmacokinetic interaction with specific systemic medicines and a physical incompatibility with certain medical devices.

Documented Systemic Drug Interactions

**Interacting Medicine** **Official Constraint / Requirement**
Oral **Tacrolimus** or Oral **Sirolimus** (Immunosuppressants) Vaginal Clomaderm may **increase the plasma levels** of these systemic drugs due to potential enzyme inhibition (CYP3A4). Patients on these medicines require **close monitoring** for signs of overdosage, including the determination of respective plasma levels if clinically necessary.

Interaction with Medical Devices

Clomaderm vaginal creams and tablets may cause damage to latex contraceptives such as condoms and diaphragms, which reduces their effectiveness and safety for preventing pregnancy and sexually transmitted diseases. Patients are officially advised to use alternative precautions for at least five days following the use of the vaginal product to mitigate this risk.

Interactions with Food, Alcohol, or Supplements

Official regulatory sources do not document any specific interactions between topical or vaginal Clomaderm and food, alcohol, or herbal products.

Mechanism of Action

Molecular Mechanism: Inhibition of Ergosterol Synthesis

The action of Clomaderm (Clotrimazole) is defined by its selective binding to and inhibition of the fungal enzyme cytochrome P450 14alpha-demethylase (CYP51). This enzyme is essential for the final steps of ergosterol biosynthesis, the pathway responsible for generating the main sterol component of the fungal cell membrane.

Cellular Consequences: Membrane Structural Failure

Enzyme inhibition initiates a mechanistic cascade: the fungal cell rapidly depletes necessary ergosterol and simultaneously accumulates toxic levels of abnormal sterol precursors. This dual defect physically compromises the fungal cell membrane, leading to a loss of structural integrity and increased permeability. This uncontrolled change in membrane function and selective permeability results in the complete cessation of fungal cell growth and reproductive ability. The mechanism is constrained by fungal defenses, such as efflux pump activity, which can prevent the drug from reaching inhibitory concentrations at the CYP51 target site.

Dosage and Administration Information

Clomaderm (Clotrimazole) administration is confined to the topical (cutaneous) and intravaginal routes, utilizing specific dosage forms tailored for each application. The medicine is available as a 1% cream or solution for skin application, and as a 1% or 2% cream or 100 mg, 200 mg, or 500 mg tablets for intravaginal use.

The standard administration pattern for topical use involves applying a thin layer of the preparation to the affected area and surrounding skin twice daily, typically in the morning and evening. For common cutaneous fungal manifestations, treatment courses generally require a minimum duration of two to four weeks, and may extend up to eight weeks for conditions such as Tinea pedis. Topical use is consistent with the adult regimen for children two years of age and older.

Intravaginal treatment is prescribed with fixed regimens, which must be completed according to the established duration. The dosing ranges from a single 500 mg application to consecutive courses of three or seven days using lower-strength forms. This form is typically inserted once daily at bedtime to promote retention. Administration constraints for this route specify that the tablet or cream should be inserted deeply and that use should be avoided during menstruation. Intravaginal formulations are approved for use in patients 12 years of age and older.

Recent Clinical Evidence

Research evidence / Overview of studies for Clomaderm

The research on Clomaderm (Clotrimazole) has primarily been conducted using controlled clinical trials and systematic reviews, which contributes to the research landscape that examined various common fungal and yeast infections. The purpose of these studies is to monitor how different patient groups respond when the medicine was evaluated in a clinical setting. Studies help show what has been observed so far regarding symptom patterns and fungal clearance.

Evidence for use in Superficial Skin Fungal Infections

The core evidence for using Clomaderm for skin fungal infections—such as athlete's foot (Tinea pedis) and ringworm (Tinea corporis)—comes from numerous short-term Randomized Controlled Trials (RCTs). These studies research examined different formulations against either placebo or other topical antifungal agents. Researchers studies monitored outcomes in adult participants, focusing on two key measures: mycological clearance (absence of the fungus in lab tests) and clinical assessment scores, which tracked the evolution of visible signs like itching and redness.

Findings describe patterns observed in the studies where, following short-term treatment, measurements of fungal clearance was documented across the observed populations. However, existing studies provide limited information on long-term study results. The follow-up durations were limited, meaning research exploring short-term symptom changes does not determine whether an individual will respond similarly after an extended period.

Evidence for use in Vulvovaginal Candidiasis

The evidence for the intravaginal use of Clomaderm is based on a high volume of systematic reviews, meta-analyses, and comparative RCTs that researched examined various dosing schedules. Key outcomes monitored included the mycological clearance rate and the clinical assessment outcome, which focused on changes in patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies where groups using Clomaderm reported a consistent documentation of mycological clearance.

What is Still Uncertain about Clomaderm Studies

While the evidence base for Clomaderm is extensive, several research limitations exist. Follow-up durations were limited, meaning there is limited information on long-term study results regarding recurrence or sustained clearance. Furthermore, data for certain groups remain insufficient, meaning subgroup findings are uncertain for many specific patient groups, such as those with weakened immune systems or those whose infections are caused by rare fungal species.

Frequently Asked Questions (FAQ)

Common questions about Clomaderm (FAQ)

Q: What is Clomaderm used to treat?

Clomaderm is officially indicated for the treatment of inflammatory and itchy skin conditions that are known to respond to topical corticosteroids. According to regulatory documents, this includes conditions where the skin is inflamed, red, and causing discomfort. Its intended use is to help reduce these symptoms by acting on the affected area.

Q: Is Clomaderm an antibiotic?

No, Clomaderm is a topical corticosteroid, not an antibiotic. Corticosteroids work by reducing inflammation and suppressing the immune response in the skin. Studies and official information confirm that it does not treat bacterial infections directly.

Q: Can I use Clomaderm on my face?

Regulatory documents state that use on sensitive areas, such as the face, groin, or armpits (axillae), is subject to limitations. Regulatory warnings emphasize that, when used on these areas, application should be limited to the shortest duration and least amount necessary. This caution is intended to minimize the risk of potential side effects in areas with thinner skin.

Q: Will Clomaderm cure my eczema permanently?

Official information indicates that Clomaderm, like other topical corticosteroids, is designed to manage the symptoms of chronic skin conditions. It is used to treat the inflammation and itching associated with a flare-up. It does not provide a permanent cure for the underlying condition.

Q: Can I use Clomaderm if I have a fungal infection?

According to the official product information, Clomaderm is not recommended for use alone if a fungal, viral, or bacterial skin infection is present. Corticosteroids can sometimes worsen these infections or mask the signs of them. Official information indicates that use alongside appropriate anti-infective therapy may be necessary in such cases, and this should be determined by a healthcare provider.

Q: Should I cover the treated skin with a bandage?

Regulatory documents indicate that the use of occlusive dressings (e.g., tight wraps or bandages) is generally discouraged unless directed by a healthcare professional. Covering the treated area can significantly increase the absorption of the medicine into the body. This increased absorption can potentially raise the risk of experiencing systemic side effects.

How should Clomaderm be stored and disposed of?

How to Store and Dispose of Clomaderm?

The official regulatory profile for Clomaderm (Clotrimazole) defines strict requirements to maintain its stability and ensure safety.

Storage Requirements

Constraint Official Rule
Temperature Store at controlled room temperature, typically between 20 C to 25 C.
Environment Must be kept away from excess heat, moisture, and direct light. Do not freeze the product.
Packaging Keep the medicine in its original container with the lid tightly closed.

Safety and Disposal

The medicine must be kept out of the sight and reach of children. To dispose of expired or unused Clomaderm, regulatory guidance advises against flushing it down the toilet or pouring it down a drain. Instead, the product should be taken to a formal drug take-back program or mixed with an unappealing substance, sealed in a bag, and discarded in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Clomaderm found in:

A-Z Index: